When to Refer a Patient with Thrombocytopenia
Patients with thrombocytopenia (platelet count <150 × 10³/μL) should be referred to secondary care immediately if the platelet count is <50 × 10³/μL or if there are any signs of active bleeding regardless of platelet count. 1
Referral Thresholds Based on Platelet Count
- Immediate referral to emergency department for patients who are acutely unwell with thrombocytopenia of any severity 2
- Immediate referral to secondary care for confirmed thrombocytopenia with platelet count <50 × 10³/μL 2, 3
- Urgent outpatient referral for stable patients with platelet counts between 50-100 × 10³/μL 1
- Routine referral for stable patients with persistent mild thrombocytopenia (100-150 × 10³/μL) without clear etiology 1, 4
Referral Based on Clinical Presentation
Immediate Referral Regardless of Platelet Count
- Patients with active bleeding manifestations (petechiae, purpura, ecchymosis) 1
- Suspected vaccine-induced immune thrombocytopenia and thrombosis (VITT) with thrombosis 2
- Cancer-associated thrombosis with thrombocytopenia 2
- Suspected thrombotic microangiopathies or heparin-induced thrombocytopenia 1
- Pregnant patients with thrombocytopenia (possible HELLP syndrome) 1
Special Considerations for Referral
- Trauma patients: Refer immediately if platelet count <100 × 10³/μL, especially with traumatic brain injury or massive hemorrhage 2
- Cancer patients on anticoagulation: Refer when platelet count falls below 50 × 10³/μL for anticoagulation management 2, 3
- Patients requiring invasive procedures: Refer if platelet count <50 × 10³/μL for transfusion consideration prior to procedure 2, 5
Follow-up After Initial Evaluation
For patients with platelet counts 50-150 × 10³/μL without symptoms:
For patients with platelet counts 20-50 × 10³/μL:
For patients with platelet counts <20 × 10³/μL:
Pitfalls to Avoid
- Don't assume mild thrombocytopenia (100-150 × 10³/μL) is always benign; it may be the first sign of a serious underlying condition 1, 4
- Don't delay referral for patients on anticoagulants who develop thrombocytopenia, as dose adjustments are critical when counts fall below 50 × 10³/μL 2, 3
- Don't miss VITT by focusing only on platelet count; consider recent COVID-19 vaccination (5-30 days prior) and presence of thrombosis 2
- Don't forget to repeat platelet counts after 2-3 days if clinical suspicion remains high despite initial normal or borderline results 2